Deep dives, evidence grades, and clinical tools, all in one place.
Practice Signal
Pharmacist Prescribing and Test-and-Treat Models
Ambulatory Care / MTM5 sources · Updated Nov 16, 2026
This review helps pharmacists judge which protocol-based prescribing and test-and-treat services have supporting evidence, and which design and governance elements determine whether they work in practice.
Bottom Line
Across community strep testing, emergency department culture callbacks, post-discharge result review, and remote blood pressure management, pharmacist prescribing under protocols shows consistent process gains, but the evidence is low certainty, outcome benefit is unproven, and success depends more on infrastructure, triage rules, and patient follow-through than on pharmacist clinical willingness.
0.30
AOR, pharmacy antibiotic provision
91%–97%
managed without GP referral
53.8
point gain, appropriate therapy
−3.4 mmHg
extra systolic drop, RPM completers
State of Play
Pharmacist prescribing under protocols and collaborative practice agreements (CPAs) is broadly accepted for low-risk, protocol-driven conditions, and support drops for complex or high-risk therapy. The current evidence base is almost entirely observational, descriptive, or qualitative, graded low or very low, and it consistently measures process (antibiotic supply, appropriateness, protocol adherence, blood pressure change) rather than patient outcomes.
🔒
Full Analysis: Subscribers Only
The complete evidence synthesis, practice recommendations, and open questions.
What Changed
How It Fits the Guidelines
Effect chart & evidence comparison
Evidence at a Glance
Practice Considerations
Open Questions
Founding member rate
$8/month. Cancel anytime.
One subscription unlocks this Practice Signal, every other Signal, and every deep analysis we publish, plus PDF reports.
Each Practice Signal is built from our published deep analyses and checked for clinical accuracy before it goes live.
Not medical advice. PharmD Signal provides educational synthesis of published pharmacy and medical literature for practicing pharmacists. It is not a treatment recommendation for any individual patient; clinical decisions remain the responsibility of the treating clinician exercising independent professional judgment.